Trials / Completed

CompletedNCT05530122

Prognosis in UC After First Biological

The Long-term Outcome of Patients With Ulcerative Colitis Treated With First Trial of Biological.

Status: Completed
Phase: —
Study type: Observational
Enrollment: 192 (actual)

Sponsor: Tampere University Hospital · Academic / Other
Sex: All
Age: 16 Years
Healthy volunteers: —

Summary

To study the long-term clinical outcome of patients with ulcerative colitis treated with first trial of biological therapy.

Detailed description

UC patients treated with at least one biological in Tampere University Hospital between January 2009 and January 2020 were identified and reviewed from patient records.

Conditions

Ulcerative Colitis

Interventions

Type	Name	Description
BIOLOGICAL	infliximab, adalimumab, golimumab, vedolizumab, ustekinumab

Timeline

Start date: 2009-01-01
Primary completion: 2020-01-01
Completion: 2022-08-26
First posted: 2022-09-07
Last updated: 2022-09-07

Source: ClinicalTrials.gov record NCT05530122. Inclusion in this directory is not an endorsement.